Survivin as a Preferential Target for Cancer Therapy

Simple item page
dc.contributor.authorMobahat, Mahsaen_US
dc.contributor.authorNarendran, Aruen_US
dc.contributor.authorRiabowol, Karlen_US
dc.date.accessioned2014-06-20T21:42:22Z
dc.date.available2014-06-20T21:42:22Z
dc.date.issued2014-02-13
dc.descriptionArticle deposited according to MDPI’s policy for International Journal of Molecular Sciences: http://www.mdpi.com/authors June 20, 2014en_US
dc.description.refereedYesen_US
dc.description.sponsorshipFunding provided by the Open Access Authors Fund.en_US
dc.identifier.citationInt. J. Mol. Sci. 2014, 15, 2494-2516; doi:10.3390/ijms15022494en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/33724
dc.identifier.urihttp://hdl.handle.net/1880/50111
dc.language.isoengen_US
dc.publisherMultidisciplinary Digital Publishing Instituteen_US
dc.publisher.corporateUniversity of Calgaryen_US
dc.publisher.facultyMedicineen_US
dc.publisher.urlwww.mdpi.com/journal/ijmsen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleSurvivin as a Preferential Target for Cancer Therapyen_US
dc.typejournal article
thesis.degree.disciplineBiochemistry and Molecular Biologyen_US
thesis.degree.disciplinePediatrics
thesis.degree.disciplineOncology
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2014_InternationalJournalofMolecularSciences_Riabowol.pdf
Size:
447.75 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.84 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Cumming School of Medicine Research & Publications